Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Long-term extended-interval teclistamab and talquetamab dosing without step-up dosing in previously treated multiple myeloma.
Journal: Experimental hematology & oncology
Published: May 22, 2026
Is Pseudo-progression post-CAR T therapy real?
Journal: Clinical hematology international
Published: January 11, 2026
Outpatient Administration of Bispecific Antibody Therapy for Hematologic Malignancies: A Practical Guide.
Journal: JCO oncology practice
Published: December 04, 2025
Brexucabtagene Autoleucel in the Outpatient Setting: A Single-Institution Experience.
Journal: Transplantation and cellular therapy
Published: November 14, 2025
Feasibility of outpatient administration of ciltacabtagene autoleucel and reduction in healthcare utilization cost: the Vanderbilt experience.
Journal: Bone marrow transplantation
Published: October 18, 2025
Outcomes of hematopoietic stem cell transplantation in patients aged 70 years and older.
Journal: Bone marrow transplantation
Published: October 09, 2025
Flat dose intravenous immunoglobulin primary infection prophylaxis in multiple myeloma patients on BCMA and GPRC5D bispecific antibody therapy: the Vanderbilt experience.
Journal: Frontiers in immunology
Published: October 09, 2025
Impact of Granulocyte Colony Stimulating Factor Use Following CD-19 Chimeric Antigen Receptor T-Cell Therapy.
Journal: Transplantation and cellular therapy
Published: May 24, 2025
Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trial.
Journal: Bone marrow transplantation
Published: January 20, 2025
No Role for Tandem Autologous Stem Cell Transplantation in Modern Treatment Paradigms for Transplant Eligible Multiple Myeloma.
Journal: Transplantation and cellular therapy
Published: August 23, 2024
Multidisciplinary Management of Morbidities Associated with Chronic Graft-Versus-Host Disease.
Journal: Clinical hematology international
Published: June 17, 2024
SARS-CoV2 is not just infection but a culprit of donor graft failure post-allogeneic stem cell transplant.
Journal: Clinical hematology international
Published: April 25, 2024
Last Updated: 09/26/2026